Yıl: 2016 Cilt: 16 Sayı: 6 Sayfa Aralığı: 412 - 418 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score

Öz:
Objective: Although various risk stratification models are available and currently being used, the performance of these models in different populations is still controversial. We aimed to investigate the relation between the Framingham and SCORE models and the presence and severity of coronary artery disease, which is detected using the SYNTAX score.Methods: The observational cross-sectional study population consisted of 227 patients with a mean age of 63.3±9.2 years. The patients were classified into low- and high-risk groups in the Framingham and SCORE models separately. Following coronary angiography, the patients were classified into SYNTAX=0 (SYNTAX score 0), low SYNTAX (SYNTAX score 1-22), and high SYNTAX (SYNTAX score>22) groups. The relation between the risk models and SYNTAX score was evaluated by student t test, Mann-Whitney U test or Kruskal-Wallis test and Receiver operating characteristic analysis were used to detect the discrimination ability in the prediction of SYNTAX score>0 and a high SYNTAX score.Results: Both the Framingham and SCORE models were found to be effective in predicting the presence of coronary artery disease, and neither of the two models had superiority over each other [AUC=0.819 (0.767, 0.871) vs. 0.811 (0.757, 0.861), p=0.881]. Furthermore, both models were also effective in predicting the extent and severity of coronary artery disease [AUC=0.724 (0.656, 0.798) vs. 0.730 (0.662, 0.802), p=0.224]. When the subgroups were analyzed, the SCORE model was found to be better in predicting coronary artery disease extent and severity in subgroups of men and diabetics {[AUC=0.737 (0.668, 0.844) vs. 0.665 (0.560, 0.790), p=0.019], [AUC=0.733 (0.684, 0.798) vs. 0.680 (0.654, 0.750) p=0.029], respectively).Conclusion: In addition to their role in predicting cardiovascular events, the use of the Framingham and SCORE models may also have utility in predicting the extent and severity of coronary artery disease. The SCORE risk model has a slightly better performance than the Framingham risk model.
Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-53.
  • 2. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
  • 3. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. Eurointervention 2005; 1: 219-27.
  • 4. Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009; 5: 50-6.
  • 5. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-72.
  • 6. Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, et al. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007; 99: 1072-81.
  • 7. Capodanno D, Di Salvo ME, Cincotta G, Miano M, Tamburino C, Tamburino C. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Intervent 2009; 2: 302-8.
  • 8. Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, et al. 5-Year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus- eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 2010; 55: 1093-101.
  • 9. Wykrzykowska J, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, et al. Value of the Syntax Score (SX) for risk assessment in the "All- comers" Population of the Randomized Multicenter Leaders Trial. J Am Coll Cardiol 2010; 56: 272-7.
  • 10. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis 2007; 194: 1-45.
  • 11. SYNTAX working-group. SYNTAX score calculator: Available at URL: www.syntaxscore.com. Accessed date at September 2012.
  • 12. Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, et al. Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study. BMJ 2003; 327: 1267.
  • 13. Empana JP, Ducimetiere P, Arveiler D, Ferrieres J, Evans A, Ruidavets JB, et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003; 24: 1903-11.
  • 14. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany: results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003; 24: 937-45.
  • 15. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function- based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21: 365-70.
  • 16. Orford JL, Sesso HD, Stedman M, Gagnon D, Vokonas P, Gaziano JM. A comparison of the Framingham and European Society of Cardiology coronary heart disease risk prediction models in the normative aging study. Am Heart J 2002; 144: 95-100.
  • 17. Thomsen TF, McGee D, Davidsen M, Jorgensen T. A cross-validation of risk- scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002; 31: 817-22.
  • 18. Liu J, Hong Y, D'Agostino RB Sr, Wu Z, Wang W, Sun J, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese MultiProvincial Cohort Study. JAMA 2004; 291: 2591-9.
  • 19. Ulmer H, Kollerits B, Kelleher C, Diem G, Concin H. Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44 649 Austrian men and women. Eur J Cardiovasc Prev Rehabil 2005; 12: 433-41.
  • 20. Neuhauser HK, Ellert U, Kurth BM. A comparison of Framingham and SCORE-based cardiovascular risk estimates in participants of the German National Health Interview and Examination Survey 1998. Eur J Cardiovasc Prev Rehabil 2005; 12: 442-50.
  • 21. Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G. Predicted and observed cardiovascular disease in South Asians: application of FINRISK, Framingham and SCORE models to Newcastle Heart Project data. J Public Health 2005; 27: 93-100.
  • 22. Scheltens T, Verschuren WM, Boshuizen HC, Hoes AW, Zuithoff NP, Bots ML, Grobbee DE. Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age. Eur J Cardiovasc Prev Rehabil 2008; 15: 562-6.
  • 23. Selvarajah S, Kaur G, Haniff J, Cheong KC, Hiong TG, van der Graaf Y, et al. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population. Int J Cardiol 2014; 176: 211-8.
  • 24. Marchant I, Boissel JP, Kassaï B, Bejan T, Massol J, Vidal C, et al. SCORE should be preferred to Framingham to predict cardiovascular death in French population. Eur J Cardiovasc Prev Rehabil 2009; 16: 609-15.
  • 25. Erkan H, Vatan B, Ağaç MT, Korkmaz L, Erkan M, Kırış A, et al. Relationship between SYNTAX score and Trans-Atlantic InterSociety Consensus II classification in patients undergoing diagnostic angiography. Postepy Kardiol Interwencyjnej 2013; 9: 344-7.
APA günaydın z, KARAGÖZ A, Bektaş O, KAYA A, KIRIŞ T, erdogan g, IŞIK T, AYHAN E (2016). Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. , 412 - 418.
Chicago günaydın zeki yüksel,KARAGÖZ Ahmet,Bektaş Osman,KAYA Ahmet,KIRIŞ TUNCAY,erdogan güney,IŞIK Turgay,AYHAN Erkan Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. (2016): 412 - 418.
MLA günaydın zeki yüksel,KARAGÖZ Ahmet,Bektaş Osman,KAYA Ahmet,KIRIŞ TUNCAY,erdogan güney,IŞIK Turgay,AYHAN Erkan Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. , 2016, ss.412 - 418.
AMA günaydın z,KARAGÖZ A,Bektaş O,KAYA A,KIRIŞ T,erdogan g,IŞIK T,AYHAN E Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. . 2016; 412 - 418.
Vancouver günaydın z,KARAGÖZ A,Bektaş O,KAYA A,KIRIŞ T,erdogan g,IŞIK T,AYHAN E Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. . 2016; 412 - 418.
IEEE günaydın z,KARAGÖZ A,Bektaş O,KAYA A,KIRIŞ T,erdogan g,IŞIK T,AYHAN E "Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score." , ss.412 - 418, 2016.
ISNAD günaydın, zeki yüksel vd. "Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score". (2016), 412-418.
APA günaydın z, KARAGÖZ A, Bektaş O, KAYA A, KIRIŞ T, erdogan g, IŞIK T, AYHAN E (2016). Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. The Anatolian Journal of Cardiology, 16(6), 412 - 418.
Chicago günaydın zeki yüksel,KARAGÖZ Ahmet,Bektaş Osman,KAYA Ahmet,KIRIŞ TUNCAY,erdogan güney,IŞIK Turgay,AYHAN Erkan Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. The Anatolian Journal of Cardiology 16, no.6 (2016): 412 - 418.
MLA günaydın zeki yüksel,KARAGÖZ Ahmet,Bektaş Osman,KAYA Ahmet,KIRIŞ TUNCAY,erdogan güney,IŞIK Turgay,AYHAN Erkan Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. The Anatolian Journal of Cardiology, vol.16, no.6, 2016, ss.412 - 418.
AMA günaydın z,KARAGÖZ A,Bektaş O,KAYA A,KIRIŞ T,erdogan g,IŞIK T,AYHAN E Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. The Anatolian Journal of Cardiology. 2016; 16(6): 412 - 418.
Vancouver günaydın z,KARAGÖZ A,Bektaş O,KAYA A,KIRIŞ T,erdogan g,IŞIK T,AYHAN E Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score. The Anatolian Journal of Cardiology. 2016; 16(6): 412 - 418.
IEEE günaydın z,KARAGÖZ A,Bektaş O,KAYA A,KIRIŞ T,erdogan g,IŞIK T,AYHAN E "Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score." The Anatolian Journal of Cardiology, 16, ss.412 - 418, 2016.
ISNAD günaydın, zeki yüksel vd. "Comparison of the Framingham risk and SCORE models in predicting the presence and severity of coronary artery disease considering SYNTAX score". The Anatolian Journal of Cardiology 16/6 (2016), 412-418.